Verition Fund Management’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-188
Closed -$41K – 2643
2022
Q3
$41K Hold
188
– – ﹤0.01% 2710
2022
Q2
$90K Hold
188
– – ﹤0.01% 2093
2022
Q1
$85K Sell
188
-125
-40% -$63.8K ﹤0.01% 2451
2021
Q4
$58K Hold
313
– – ﹤0.01% 2397
2021
Q3
$100K Hold
313
– – ﹤0.01% 1710
2021
Q2
$182K Buy
+313
New +$171K ﹤0.01% 1618

Other funds holding EDVA

Verition Fund Management's EDVA Position: Q4 2022 in Review

Verition Fund Management sold out of Endovia Health Sciences, Inc. (EDVA) in Q4 2022, closing a stake of 188 shares — an estimated $41K sold.

Verition Fund Management first reported a position in EDVA in Q2 2021 and held it in 6 quarters. The position peaked at $182K in Q2 2021. 22 funds tracked by Wall St. Rank hold EDVA as of Q4 2022.

  • Verition Fund Management reported no remaining Endovia Health Sciences, Inc. position as of Q4 2022 after selling out during the quarter.
  • Verition Fund Management sold 188 Endovia Health Sciences, Inc. shares in Q4 2022, an estimated $41K.
  • Verition Fund Management first reported a position in Endovia Health Sciences, Inc. in Q2 2021 and held it in 6 quarters.
  • Verition Fund Management's Endovia Health Sciences, Inc. position peaked at $182K in Q2 2021.
  • 22 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.